679 related articles for article (PubMed ID: 21987802)
1. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
[TBL] [Abstract][Full Text] [Related]
2. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
[TBL] [Abstract][Full Text] [Related]
3. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.
Brink M; Verheul MK; Rönnelid J; Berglin E; Holmdahl R; Toes RE; Klareskog L; Trouw LA; Rantapää-Dahlqvist S
Arthritis Res Ther; 2015 Feb; 17(1):25. PubMed ID: 25889922
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity in rheumatoid arthritis: different antigens--common principles.
Trouw LA; Huizinga TW; Toes RE
Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii132-6. PubMed ID: 23253931
[TBL] [Abstract][Full Text] [Related]
7. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
8. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
9. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Hamann D; van Schaardenburg D; Toes RE; Trouw LA
Ann Rheum Dis; 2014 Apr; 73(4):780-3. PubMed ID: 24336334
[TBL] [Abstract][Full Text] [Related]
10. Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing
Brevet P; Lattard C; Guillou C; Rottenberg P; Fardellone P; Le-Loët X; Lequerré T; Cosette P; Boyer O; Fréret M; Vittecoq O
Front Immunol; 2021; 12():733511. PubMed ID: 34691039
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
[TBL] [Abstract][Full Text] [Related]
12. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.
Yee A; Webb T; Seaman A; Infantino M; Meacci F; Manfredi M; Benucci M; Lakos G; Favalli E; Schioppo T; Meroni PL; Mahler M
Immunol Res; 2015 Feb; 61(1-2):24-30. PubMed ID: 25391608
[TBL] [Abstract][Full Text] [Related]
13. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.
Nakabo S; Hashimoto M; Ito S; Furu M; Ito H; Fujii T; Yoshifuji H; Imura Y; Nakashima R; Murakami K; Kuramoto N; Tanaka M; Satoh J; Ishigami A; Morita S; Mimori T; Ohmura K
Rheumatology (Oxford); 2017 Jul; 56(7):1217-1226. PubMed ID: 28398552
[TBL] [Abstract][Full Text] [Related]
14. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
[TBL] [Abstract][Full Text] [Related]
15. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
[TBL] [Abstract][Full Text] [Related]
16. The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switching.
van Delft MAM; Verheul MK; Burgers LE; Rantapää-Dahlqvist S; van der Helm-van Mil AHM; Huizinga TWJ; Toes REM; Trouw LA
Rheumatology (Oxford); 2018 Sep; 57(9):1583-1591. PubMed ID: 29846726
[TBL] [Abstract][Full Text] [Related]
17. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
18. Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis.
Verheul MK; Yee A; Seaman A; Janssen GM; van Veelen PA; Drijfhout JW; Toes REM; Mahler M; Trouw LA
J Autoimmun; 2017 Jun; 80():77-84. PubMed ID: 28291659
[TBL] [Abstract][Full Text] [Related]
19. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
[TBL] [Abstract][Full Text] [Related]
20. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.
Scinocca M; Bell DA; Racapé M; Joseph R; Shaw G; McCormick JK; Gladman DD; Pope J; Barra L; Cairns E
J Rheumatol; 2014 Feb; 41(2):270-9. PubMed ID: 24429169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
